MDLinx Announces Standards and Quality Milestone
* Reuters is not responsible for the content in this press release.
WASHINGTON--(Business Wire)-- MDLinx, with an online community of physicians providing panel to top pharmaceutical market research companies, announces its acceptance for membership by CASRO, the Council of American Survey Research Organizations. MDLinx is now a member of MRA, PMRG, PBIRG, iMRO, and CASRO. MDLinx`s senior market research management are members of ESOMAR and have been certified by MRA with Professional Researcher Certification (PRC) within the past year - some at the expert level. "Standards and Quality go hand in hand," said William "Bill" Hoover, Director of Market Research, "and over the past 3 years we have implemented a number of quality initiatives to provide the highest level of service to our pharmaceutical market research clients. Acceptance to this premier organization is a milestone commitment to standards and quality." CASRO is the industry`s leading quality benchmark and MDLinx joins over 300 other market research companies that subscribe to the CASRO Code of Standards. The Company wants to be part of the online market research industry revolution that has been aiming for standards and quality assurance. For more than 10 years, MDLinx has been a reliable source of information for doctors. Joining a standards organization aids MDLinx`s mission to help physicians and pharma communicate and affirms a commitment to quality solutions for pharmaceutical market research companies. MDLinx is an award-winning online community of physicians founded in 1999. The US based company has the greatest reach in the physician specialist market and through an international corporate structure can access world class physician communities in Japan, Korea, and Germany. MDLinx has partners in over 120 counties worldwide, to deliver one-stop global physician recruiting. In addition, MDLinx has solutions for online physician advertising with a specialized website, newsletters, and Messages - a direct-to-physician messaging platform. For more information, visit the Company`s website at www.mdlinx.com/mr. MDLinx Aqsa Waqar, 202-293-2288 Copyright Business Wire 2009